Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  58,044 results for ""FENOFIBRATE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Amelioration of propionic acid-induced autism-like behaviors in rats by fenofibrate: A focus on reduction of brain galectin-3 levels.

  • Authors : Erdogan MA; Department of Physiology, Izmir Katip Celebi University, Faculty of Medicine, Izmir, Türkiye.; Akbulut MC

Subjects: Rats, Wistar* ; Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use

  • Source: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience [Int J Dev Neurosci] 2024 Dec; Vol. 84 (8), pp. Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 8401784 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A European, Observational, 3-Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The POSE Study.

Subjects: Pravastatin*/Pravastatin*/Pravastatin*/administration & dosage ; Pravastatin*/Pravastatin*/Pravastatin*/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Nov; Vol. 33 (11), pp. e70047.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Reactive oxygen species-sensitive fenofibrate-loaded dextran nanoparticles in alleviation of osteoarthritis.

  • Authors : Sheng W; Department of Bone & Joint Surgery, National & Local Joint Engineering Research Center of Orthopaedic Biomaterials, Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, Peking University Shenzhen Hospital, Shenzhen 518036, China.; Liao S

Subjects: Osteoarthritis*/Osteoarthritis*/Osteoarthritis*/drug therapy ; Osteoarthritis*/Osteoarthritis*/Osteoarthritis*/metabolism ; Osteoarthritis*/Osteoarthritis*/Osteoarthritis*/pathology

  • Source: Carbohydrate polymers [Carbohydr Polym] 2025 Jan 01; Vol. 347, pp. 122768. Date of Electronic Publication: 2024 Sep 20.Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 8307156 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study.

  • Authors : Alarfaj SJ; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.; Bahaa MM

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; Fenofibrate*/Fenofibrate*/Fenofibrate*/administration & dosage ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy

  • Source: Drug design, development and therapy [Drug Des Devel Ther] 2024 Nov 16; Vol. 18, pp. 5239-5253. Date of Electronic Publication: 2024 Nov 16 (Print Publication: 2024).Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Fenofibrate induces liver enlargement in aging mice via activating the PPARα-YAP signaling pathway.

  • Authors : Li H; NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; PPAR alpha*/PPAR alpha*/PPAR alpha*/metabolism ; Signal Transduction*/Signal Transduction*/Signal Transduction*/drug effects

  • Source: Chemico-biological interactions [Chem Biol Interact] 2025 Jan 05; Vol. 405, pp. 111286. Date of Electronic Publication: 2024 Oct 21.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0227276 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7786

Record details

Read More Add to Saved list
×
Academic Journal

Bioavailability improvement by atomic layer coating: Fenofibrate a case study.

  • Authors : Ganapathy B; Applied Materials India Pvt. Ltd., IIT-Bombay, Powai, Maharashtra, India. Electronic address: .; Redasani V

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/chemistry ; Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacokinetics ; Fenofibrate*/Fenofibrate*/Fenofibrate*/administration & dosage

  • Source: Journal of pharmaceutical sciences [J Pharm Sci] 2025 Jan; Vol. 114 (1), pp. 617-625. Date of Electronic Publication: 2024 Nov 01.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial.

  • Authors : Hostrup PE; Department of Clinical Research, Steno Diabetes Center Copenhagen, Copenhagen University Hospital, Herlev, Denmark. .; Schmidt T

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/blood

  • Source: Diabetologia [Diabetologia] 2025 Jan; Vol. 68 (1), pp. 29-40. Date of Electronic Publication: 2024 Oct 30.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Reduction of Alcohol-Dependent Lung Pathological Features in Rats Treated with Fenofibrate.

  • Authors : Rojas DA; Instituto de Ciencias Biomédicas (ICB), Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago 8910132, Chile.; Coronado K

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/pharmacology ; Lung*/Lung*/Lung*/pathology ; Lung*/Lung*/Lung*/drug effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Nov 28; Vol. 25 (23). Date of Electronic Publication: 2024 Nov 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2024 Nov; Vol. 15 (11), pp. 1663-1668. Date of Electronic Publication: 2024 Aug 22.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Melt-extruded formulations of fenofibrate with various grades of hydrogenated phospholipid exhibit promising in-vitro biopharmaceutical behavior.

  • Authors : Czajkowski M; Department of Inorganic & Analytical Chemistry, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland; Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, Odense 5230, Denmark.

Subjects: Fenofibrate*/Fenofibrate*/Fenofibrate*/chemistry ; Phospholipids*/Phospholipids*/Phospholipids*/chemistry ; Hypolipidemic Agents*/Hypolipidemic Agents*/Hypolipidemic Agents*/chemistry

  • Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Dec 01; Vol. 203, pp. 106936. Date of Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  58,044 results for ""FENOFIBRATE""